IMF says Covid-19 economic crisis 'far from over', more support needed

Topics Coronavirus | IMF | Economic Crisis

IMF estimates the total cost of the crisis will reach $12 trillion by the end of 2021, with low-income countries likely to need continued support.
The International Monetary Fund on Wednesday warned that the coronavirus crisis was “far from over” and underscored the need for multilateral cooperation to ensure adequate supplies once a vaccine is developed.

In an essay published in Foreign Policy magazine, IMF Managing Director Kristalina Georgieva and chief economist Gita Gopinath said the ongoing economic recovery from the crisis was the result of the rapid implementation and unprecedented scale of government and central bank support, but more efforts would be needed.

“The recovery remains very fragile and uneven across regions and sectors. To ensure that the recovery continues, it is essential that support not be prematurely withdrawn,” the two economists wrote in the essay.

Covid-19, the disease caused by the new coronavirus has killed 900,000 worldwide, and the IMF estimates the total cost of the crisis will reach $12 trillion by the end of 2021, with low-income countries likely to need continued support.

The IMF has provided emergency funding to 75 countries, including 47 low-income countries, and said it was ready to provide further support to a wider range of middle-income countries.

In addition to supporting workers and businesses, and investing to arrest global warming and reverse rising inequality, the IMF leaders said governments must cooperate internationally to bring the health crisis to an end.

As of Sept. 8, at least 128 vaccines were under development, and 37 had reached human trials, they wrote, forecasting a 90% chance of developing a successful product.

But global cooperation was needed to ensure timely production, adequate supplies for all countries, regardless of their financial means, and an equitable distribution.

The IMF officials lauded creation of COVAX, a global Covid-19 vaccine allocation plan co-led by the World Health Organization that is backed by 76 rich countries, but not the United States.

“Globally synchronized, equitable vaccine distribution is in every country’s interest,” they wrote. “An uneven rollout might improve economic conditions in countries that secured the vaccine first but would not shield them from weak demand from trade partners struggling to recover without a vaccine.”


Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel